Network of Excellence
The Cystic Fibrosis Foundation's Research Development Program (RDP) is a network of research centers that brings together top-notch scientists from different disciplines to apply their expertise to the challenges of treating cystic fibrosis.
Since the first RDP center was established in 1981 at the University of Alabama at Birmingham, the network has evolved into eight basic science research “hubs” around the country. These programs have been instrumental in advancing our understanding of the folding defect of the F508del-CFTR protein, the airway microbiome, and the mucus defect in CF airways.
In addition to fostering a collaborative research environment to advance research into the disease, RDP centers also serve as supply centers that develop and share standardized tools and resources with researchers around the world.
RDP scientists have the opportunity to communicate directly with medical teams at nearby CF Foundation-accredited care centers, gaining firsthand insights into how their work at the “bench” might lead to therapies that will make a significant difference in the lives of people battling this disease.
State | Research Center |
Alabama |
University of Alabama at Birmingham |
Iowa |
University of Iowa |
New Hampshire |
Geisel School of Medicine at Dartmouth |
North Carolina |
University of North Carolina at Chapel Hill |
Ohio |
Case Western Reserve University |
Ohio |
Cincinnati Children's Hospital Medical Center |
Ohio |
Nationwide Children's Hospital and The Ohio State University Directors: Karen McCoy, MD, Chief of the Section of Pulmonary Medicine; and Daniel Wozniak, PhD, Professor and Vice Chair, Microbial Infection and Immunity |
Washington |
University of Washington School of Medicine |